Quick Takeaways
- Mark Bachleda has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $11,770.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Mark Bachleda
- Location
- Malvern, PA
- Summary
- The estimated net worth of Mark Bachleda is at least $11,770 dollars as of 11 Jun 2025. Mark Bachleda is the Chief Commercial Officer of Galera Therapeutics, Inc. and owns shares of Galera Therapeutics, Inc. (GRTX) stock worth about $11.8K.
- Signature
- /s/ Charles Newton as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Mark Bachleda and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Galera Therapeutics, Inc. ($11,770).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Mark Bachleda
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GRTX | Galera Therapeutics, Inc. | Chief Commercial Officer | $11,770 | 16 Mar 2023 | ||
| LYEL | Lyell Immunopharma, Inc. | Director | 09 Jun 2025 |
Insider Transactions Reported by Mark Bachleda:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.